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ABSTRACT Endoparasitic wasps of lepidopteran insects
must induce changes in host immunity and development to
survive. Depending on the species, this may require wasp
venom proteins and/or a polydnavirus. We describe an im-
munological and genetic relationship between the Campoletis
sonorensis polydnavirus and the wasp's venom gland. Mono-
clonal antibodies raised against venom glands recognized
epitopes conserved on several polydnavirus proteins and on
multiple wasp oviduct and venom proteins. The viral envelope
proteins had molecular masses of 16, 20, 45, and 50 kDa, while
a complex of at least five immunoreactive venom-gland and
soluble oviduct proteins ranged in size from 24 to 36 kDa. Since
the conserved epitopes were present on the viral envelope,
neutralization assays were performed. Monoclonal antibodies
added to purified virus blocked the normal viral inhibition of
host growth and development. To determine whether venom
mRNA and viral genes were also related, venom-related cDNA
clones were isolated from the wasp oviduct with a venom-gland
cDNA probe. Venom-related viral clones were then identified
and selected from a viral genomic library and from a parasi-
tized Heliothis virescens cDNA library. Venom-related mRNAs
were expressed in the venom gland, the oviduct, and the
parasitized host. We propose that the immunological relation-
ship between venom and viral proteins, and the hybridization
of venom and viral genes, may reflect an evolutionary rela-
tionship in which venom gene homologs were incorporated into
the viral genome, thereby allowing viral expression of venom-
related genes and enhancing parasite survival.
Parasites possess diverse mechanisms for avoiding host
immune defenses. In insect endoparasite-host relationships
the parasitic wasp alters the immune and developmental
systems of its larval lepidopteran host to produce an envi-
ronment that allows parasite survival and development.
Because of diverse species-specific differences, the mecha-
nisms through which endoparasites disrupt host physiologi-
cal systems are largely unknown. Endoparasitic hymenop-
tera have been described in which host immune and devel-
opmental systems are altered by parasite venom secretions
(1, 2), by both venom and a polydnavirus (3-5), or by the
polydnavirus alone (6-9). Polydnaviruses have an apparently
obligate symbiotic association with some endoparasitic hy-
menoptera (10, 11) and are characterized by segmented,
double-stranded, superhelical DNA genomes that are heter-
ogeneous in size and genetic composition. The life cycle of
the Campoletis sonorensis polydnavirus (CsPDV) involves
unusual host-specific regulation and expression of viral genes
and gene families. Based on molecular and genetic analyses,
some polydnaviruses are stably integrated into the chromo-
somes of every male and female wasp and are apparently
maintained in wasp populations by vertical transmission (12,
13). The CsPDV replication is detected only in ovarian calyx
cells (14, 15) and viral DNA replication is not detected in the
lepidopteran host.
Because venom secretions from one parasite and polyd-
navirus expression from another may induce similar physi-
ological symptoms in parasitized insects that benefit parasite
survival, Tanaka (2) proposed that the role(s) of endoparasite
venoms and polydnaviruses may share a more common
evolutionary relationship than has been thought. However,
no experimental evidence has indicated that such a relation-
ship between venom and polydnavirus proteins or genes
exists. The injection of purified CsPDV into lepidopteran
host larvae induces immunological and developmental dis-
ruptions similar to natural parasitization (6-8, 16), and C.
sonorensis venom gland secretions are not essential for
endoparasite development (17).
We now report that monoclonal antibodies (mAbs) raised
against wasp venom-gland proteins also recognize epitopes
on viral envelope proteins and on wasp soluble oviduct
proteins. The same mAbs blocked virus-induced growth
inhibition and developmental arrest of the lepidopteran host.
We also show cross-hybridization between venom-gland
mRNA, viral genomic DNA, viral mRNAs expressed in
parasitized insects, and parasite chromosomal DNA. The
data indicate that venom-related (VR) genes are expressed
both by the parasite venom gland and oviduct in C. sono-
rensis female adults and by the polydnavirus in parasitized
lepidopteran larvae. The presence of conserved epitopes on
venom and viral proteins, the expression of related DNA
sequences between the parasite venom gland and CsPDV,
and the neutralization of virus-induced physiological symp-
toms by anti-venom gland mAbs suggest a functional role for
VR proteins during parasitization and may indicate an evo-
lutionary relationship between polydnavirus and venom
genes.
MATERIALS AND METHODS
C. sonorensis and Heliothis virescens rearing conditions and
CsPDV purification and DNA isolation from female oviducts
have been described (18, 19). Venom glands were dissected
in saline (19) and stored at -20°C. Soluble oviduct proteins
were collected from the top 0.5-ml fraction of a 25-50%
sucrose gradient used for CsPDV purification (18). Viral
envelopes were prepared by the method of Tweeten et al.
(20).
Immunological Methods. Polyclonal anti-CsPDV antiserum
was produced in rabbits by subcutaneous injection of 100 ,ug
ofCsPDV with Freund's complete adjuvant and three similar
virus injections at 2-week intervals in incomplete adjuvant.
Venom antiserum and mAbs were produced by injecting 300
venom glands into the peritoneum of a mouse three times at
Abbreviations: CsPDV, Campoletis sonorensis polydnavirus; mAb,
monoclonal antibody; VR, venom-related.
4961
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
4962 Microbiology: Webb and Summers
2-week intervals and then fusing the spleen cells to Sp2/0
cells (21). Hybridomas were maintained in Dulbecco's mod-
ified Eagle's medium (GIBCO) supplemented with 10%o heat-
inactivated fetal bovine serum, 4 mM glutamine (Sigma), and
50 ,ug of gentamicin per ml at 370C in 6% CO2. Hybridoma
supernatants were screened in 96-well microtiter plates in an
enzyme-linked immunosorbent assay (ELISA) by coating
each well with 1 Ag of solubilized CsPDV or 0.1 ,ug of
solubilized venom gland in ELISA wash buffer (25 mM
sodium phosphate, pH 7.2/50 mM sodium chloride/0.5%
Tween 80) (22). Hybridomas that were positive in both
screens were cloned by limiting dilution (23). Cloned super-
natants were then assayed on immunoblots. The IgG fraction
of selected mAbs was collected from cell supernatants by
affinity adsorption to protein A-Sepharose CL-4B (Sigma).
For immunoblots, proteins separated in polyacrylamide gels
were transferred to nitrocellulose in an American Bionetics
"polyblot" apparatus (24). Antigens were detected using
alkaline phosphatase-conjugated anti-rabbit or anti-mouse
IgG (Promega) (25). CsPDV neutralizing assays were per-
formed by incubating CsPDV (1.25 ,ug/,l) with affinity-
purified mAbs (0.5 ,ug/,ul) or control rabbit IgG for 1 hr in
phosphate-buffered saline. Two microliters of the virus/
antibody mixture was then injected into New stage (26)
fifth-instar larvae. Larval growth and developmental stages
were monitored daily until metamorphosis or death.
DNA/RNA Methods. RNA extraction and oligo(dT)-
cellulose chromatography were performed as described (27).
Venom-gland cDNA was synthesized from 5 ,ug of total
venom-gland RNA by using a commercially available kit
(Bethesda Research Laboratories). DNA and RNA blotting,
hybridizations, and probe synthesis were performed as de-
scribed (27-29). Reduced- and high-stringency hybridizations
and washes have been described (27, 30). For sequential
hybridization of blots, probes were removed by two 30-min
washes with 15 mM sodium chloride/1.5 mM sodium citrate,
pH 7/1% SDS at 1000C.
cDNA clones were isolated from existing AgtlO C. sono-
rensis oviduct and parasitized H. virescens cDNA libraries
(15) and subcloned into Bluescribe vectors (Stratagene).
Viral genomic clones were isolated by hybridization to VR
cDNAs from a viral genomic library constructed in AZAP
(Stratagene). CsPDV DNA was digested with 0.5 units ofHae
III, Tha I, and Rsa I per ,g ofDNA at 37°C for 5 minm EcoRI
linkers (Promega) were added, and inserts were ligated into
AZAP.
RESULTS
Viral, Wasp Venom, and Oviduct Epitopes Are Conserved.
Polyclonal antisera to CsPDV and wasp venom were initially
used to compare C. sonorensis venom and viral antigens.
Viral antiserum reacted with venom proteins and venom
antiserum bound to viral structural proteins (data not shown).
Interestingly, soluble oviduct proteins also crossreacted with
polyclonal venom and virus antisera. To enhance the spec-
ificity ofthe immune response, mAbs were produced using C.
sonorensis venom glands as antigens. To select mAbs that
recognized the conserved epitopes, hybridomas were
screened in ELISAs against purified viral structural proteins,
soluble venom proteins, and soluble oviduct proteins. Only
those hybridomas which reacted with both CsPDV and the
soluble venom proteins were cloned. Three clones that
produced IgG antibodies were selected and designated 3B11,
2D11, and 3G3. In immunoblots of venom proteins, each of
the mAbs reacted similarly with approximately five venom
proteins with apparent molecular masses between 24 and 36
kDa (Fig. 1A). The immunoreactive soluble oviduct proteins
were similar to the venom proteins (Fig. 1B). By contrast, the
viral immunoreactive proteins had molecular masses of 16,
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FIG. 1. Antigenic reactivity ofmAbs selected for conserved viral
and venom epitopes. (A) Individual mAbs 2D11, 3B11, and 3G3
detected epitopes from a complex ofproteins in the venom gland with
molecular sizes between 25 and 36 kDa. (B) The mAbs 2D11, 3B11,
and 3G3 were pooled and used to probe an immunoblot of gradient-
purified virus (CsPDV), soluble oviduct proteins (SO), and venom-
gland proteins (VG). Ten micrograms of solubilized protein was
loaded in each lane. Molecular size markers (kDa) are indicated at
right.
20, 45, and 50 kDa (Fig. 1B). The data show that viral proteins
share related epitopes with C. sonorensis venom proteins but
differ in number and size. The conservation of venom
epitopes among the virus, the oviduct, and the venom pro-
teins suggested the existence of a family of VR proteins.
Neutralization of CsPDV. Viral neutralization assays were
performed by incubating 2 ug of CsPDV with 1 ,ug of the
mAbs 2D11, 3B11, and 3G3 (Table 1). For control larvae,
CsPDV was preincubated either without antibodies or with
the IgG fraction from rabbit preimmune serum and was then
injected into developmentally synchronized H. virescens
larvae. In control larvae injected with purified CsPDV,
weight gain was inhibited and development was arrested
(Table 1). Treating CsPDV with mAbs that bound VR
epitopes neutralized viral activity, since the treated virus did
not inhibit larval growth or prevent metamorphosis (Table 1).
No effects on larval growth or development occurred when
only the mAbs were injected (data not shown). Since CsPDV
injection normally causes a dramatic inhibition of larval
growth and development (Table 1), the abrogation of this
effect by prior incubation with any of the mAbs 2D11, 3B11,
and 3G3 showed that each of these mAbs blocked the effects
of the virus on the host insect.
Localization of VR Proteins on CsPDV. To study the VR
viral proteins, the virus was fractionated into envelope and
nucleocapsid. The envelope fraction was isolated with Noni-
det P-40 and separated from the nucleocapsid by centrifuga-
tion in a glycerol gradient. The purity of the envelope and
nucleocapsid preparations was visually verified by electron
microscopy and by polyacrylamide gel electrophoresis of
gradient fractions. After centrifugation of intact virus, viral
proteins were detected in fractions 7-11 and in the gradient
pellet, which was presumably due to virus aggregation. After
Nonidet P-40 treatment, the envelope proteins remained at
the top of the gradient while the nucleocapsid pelleted (data
not shown). By protein immunoblot analysis, only those
gradient fractions containing intact virus or the viral envelope
reacted with anti-venom mAbs. No VR viral proteins were
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Table 1. Neutralizing activity of VR mAbs
Mock CsPDV R-IgG VR mAbs
Day (n =8) (n = 8) (n = 24) (n =30)
Larval weight, mg
0 112 12 97 ± 11 110 ± 6 114± 14
1 129 10 100 ± 14 114 ± 10 133± 5
2 184 27 101 ± 18 127 ± 15 238± 8*
3 281 24 122 ± 29 185 ± 16 301 13*
4 344 ± 33 147 ± 35 221 ± 18 352 10*
5 397 ± 44 170 ± 38 246 ± 16 328 10*
6 t 186 ± 44 278 ± 15 338t
Percent wandering
0 0 0 0 0
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
4 0 0 0 3.3
5 37 0 4.2 80
6 100 0 8.4 87t§
CsPDV injection suppresses host growth and inhibits develop-
ment. Viral neutralization activity was indicated by normal larval
growth and metamorphosis after injection of antibody-treated virus.
Data from individual VR mAb neutralization experiments were
similar and were pooled. Neutralization of viral effects on growth is
indicated by normal weight gain after virus injection. Larval weight
(mean ± SE) on days 0-6 following mock injection (mock), injection
of 2 tig of CsPDV, injection of 2 Ag of CsPDV preincubated with 1
,ug of preimmune rabbit IgG (R-IgG), or injection of 2 ,g of CsPDV
preincubated with VR mAb 2D11, 3B11, or 3G3 is shown. n, Number
of larvae in each treatment. Neutralization of developmental effects
by VR mAbs is indicated by metamorphosis after virus injection. The
term wandering is used to describe the initiation of metamorphosis
and is indicated by morphological, physiological, and behavioral
changes in the developing larvae.
*Significantly different from CsPDV injection (P > 0.05).
tAIl surviving larvae had initiated morphogenesis.
tNo SE since only two larvae had not wandered at this time.
WFour larvae died on days 5-6.
detected in the nucleocapsid pellet (Fig. 2). Thus, mAbs that
blocked viral effects in the lepidopteran host recognized VR
epitopes on the CsPDV envelope.
Cloned Viral DNA Sequences Hybridize to mRNA from
Venom Gland and from Parasitized H. virescens. Since venom-
gland tissue was difficult to isolate for standard cDNA cloning,
VR cDNA clones were selected from an existing parasite
oviduct cDNA library (15). To do this cDNA was synthesized
from venom-gland mRNA and used as a hybridization probe
to identify and select a crossreacting oviduct cDNA clone,
pcCsl300. A viral genomic clone, pV1100, was then isolated
that also hybridized to venom-gland mRNA. To determine
whether these VR clones were related to any of the previously
described viral genes, DNA dot blot hybridization analysis
was performed with 34 cloned viral DNAs representing viral
genes and DNA segments that are expressed in both the
parasite and its host (15, 16, 31). Hybridization was observed
to the viral clones partially encoding the abundant 1.1- and
1.4-kilobase (kb) viral mRNAs that are expressed in the
parasitized host (data not shown and ref. 31). This indicated
that VR CsPDV genes are also expressed after parasitization.
To confirm this, acDNA clone that hybridized to venom-gland
mRNA was isolated from a 48-hr parasitized H. virescens
cDNA library. This viral, VR cDNA clone, pcVHv900, also
hybridized to the 1.1- and 1.4-kb mRNAs (data not shown).
Under reduced stringency, the oviduct cDNA and VR viral
cDNA and genomic clones hybridized to venom-gland RNA,
oviduct RNA, and viral DNA (Fig. 3A). Under stringent
conditions the oviduct cDNA clone hybridized to parasite
chromosomal DNA but did not hybridize to viral DNA (Fig.
3B). When the same blot was probed with the VR viral clones
pV1100 and pcHvV900, they hybridized to both viral ge-
nomic and parasite chromosomal DNA (Fig. 3B). The VR
viral clones hybridized strongly to a discrete set of CsPDV
DNA segments. Hybridization to multiple but distinct sets of
viral DNA segments has been observed in studies of CsPDV
gene families (15, 31). Viral cDNA clones from superhelical
segment W, representing mRNAs expressed in either the
wasp or its host, also hybridize to more than one viral DNA
segment but do so with genomic hybridization profiles unique
for each cDNA clone (32). In hybridizations of VR viral
clones to digested parasite chromosomal DNA, a unique set
of off-sized bands was observed. The presence of off-sized
viral DNA bands when compared with purified viral DNA is
indicative of integrated viral forms in C. sonorensis chromo-
somal DNA (12). The VR viral clones also hybridized to the
DNA bands detected in hybridizations to the VR oviduct
clone (Fig. 3B, asterisk), demonstrating that some oviduct
cDNA and viral sequences were related. These results indi-
cate that the VR oviduct cDNA clone partially encodes a VR
wasp gene that is expressed in the oviduct, and the viral
genomic clones contain related sequences that hybridize to
both the integrated chromosomal form of VR viral DNA and
to the nonviral, wasp-encoded VR genes. When the VR viral
genomic and oviduct cDNA clones were used as hybridiza-
tion probes in an RNA blot of parasitized and unparasitized
H. virescens larvae, the 1.1- and 1.4-kb mRNAs and an
additional 2.7-kb mRNA were detected only in the parasi-
tized larvae. This clearly shows that VR viral genes are
expressed after parasitization (Fig. 3C). These results
strongly indicate that a family ofVR genes is expressed in the
parasite venom gland and oviduct, and also from CsPDV in
parasitized H. virescens larvae (Fig. 3 A and C).
DISCUSSION
We describe an antigenic relationship between the secreted
wasp venom proteins and the polydnavirus structural pro-
teins which are synthesized and assembled into virus parti-
A CsPDV
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FIG. 2. Localization of VR viral pro-
teins. Viral proteins were fractionated in
a glycerol gradient by loading 200 Ag of
virus either before (A) or after (B) Noni-
det P-40 treatment. Gradient fractions of
200 1.l were removed and 20 Al of each
fraction was electrophoresed in duplicate
gels and then immunoblotted and probed
with VR mAbs. Gradient fractions are
indicated numerically from the top of the
gradient. Gradient pellets were resus-
pended in 200 p.l of phosphate-buffered
saline and designated fraction 12.
00 t.ff., * A~I,A tW.
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FIG. 3. RNA and genomic DNA blots probed with VR genes. (A) CsPDV and Autographa californica nuclear polyhedrosis virus (Ac) DNA
(1 ,ug) and C. sonorensis RNA (1 ,ug) extracted from female oviducts (ovi) and venom glands (vg) were blotted to nitrocellulose and hybridized
under conditions of reduced stringency to an oviduct VR cDNA (pcCs 1300), a viral genomic DNA clone (pV1100) and a viral, parasitized H.
virescens cDNA clone (pcHvV900). Blots were washed and exposed for 48 hr (pcCs1300) or 16 hr (pV1100 and pcHvV900). (B) A genomic DNA
blot of CsPDV (lane v) and HindIll-digested C. sonorensis DNA (lane Cs) was sequentially probed under stringent conditions with pcCsl300,
pV1100, and pcHvV900. The blot was washed and exposed for 48 hr (oviduct), or 16 hr (virus, pHv). The wasp-specific VR DNA bands are
indicated by an asterisk. HindIll-digested A phage DNA size markers are shown in kilobase pairs. (C) Poly(A)+ RNA was isolated from newly
ecdysed fifth-instar unparasitized larvae (lane np) and from similarly staged parasitized larvae 2 hr (lane p2) and 6 hr (lane p6) after parasitization,
electrophoresed, and transferred to nitrocellulose. The blot was then sequentially probed with pcCs1300, pV1100, and pcHvV900 at low
stringency, washed, and exposed for 16 hr. RNA size markers are shown (Bethesda Research Laboratories) in kilobases.
cles from the specialized calyx cells of the wasp's oviduct.
Secreted proteins from the venom gland and the oviduct
share epitopes with viral envelope proteins that differ in
number and apparent molecular weights. This suggests that
viral proteins and venom proteins share some similar protein
structure. Further, the mAbs that recognized the conserved
venom, oviduct, and viral epitopes also blocked the virus-
induced growth and developmental inhibition ofH. virescens
larvae that occurs during natural parasitization or after in-
jection of purified virus.
Oviduct cDNA and VR viral cDNA and genomic clones
were identified that, under reduced stringency, hybridized to
both viral DNA and venom-gland RNA. Under high strin-
gency, the oviduct cDNA clone hybridized only to C. sono-
rensis chromosomal DNA, while the VR viral clones hybrid-
ized to viral DNA and wasp chromosomal DNA. These viral
clones hybridized both to mRNAs that are expressed in the
venom gland and to the previously described 1.1- and 1.4-kb
mRNAs that are abundantly expressed in the parasitized host
(31). Although we have not yet established a direct relation-
ship between the VR epitopes and VR DNA clones or
mRNAs described in this study, the data show that the
description of both the proteins and the DNA sequences as
VR is valid and may indicate that at least one VR gene family
is expressed in both the parasitic wasp and its lepidopteran
host.
Endoparasitic hymenoptera evade the immune response of
their hosts and frequently alter host developmental pro-
grams. In some species no detectable polydnavirus is present
(33, 34) and venom secretions alone apparently alter host
immunity and/or development (1, 2, 35). In other endopar-
asitic hymenoptera, virus-like particles are present that are
associated with parasite-induced immunosuppressive activ-
ity but apparently lack detectable nucleic acid (36, 37). In still
other parasitic species both the polydnavirus and venom
secretions are required to suppress host development and
immunity (2, 5). For example, Stoltz et al. (5) suggested that
Cotesia melanoscela venom may facilitate viral expression
by enhancing viral uncoating. Their data indicate that both
secretions are important, if not essential, for successful
parasite development. By comparison, venom-gland removal
in C. sonorensis has no detectable effect on parasitization
efficiency (17), and purified virus is capable of producing
immunosuppressive and developmental effects (6, 7).
Our results establish that some venom and viral epitopes
are conserved, and suggest that the expression products of
parasite venom glands and polydnaviruses could be more
closely related than previously indicated by the species
diversity reported in the literature (2). That is, host venom-
related genes may have become a part of the viral genome
allowing both the supplementation and the eventual replace-
ment of venom functions by virally encoded venom ho-
mologs, or conversely. The species-specific differences in
which developmental arrest and/or immune suppression are
caused by venom and/or polydnavirus expression may re-
flect different points in the evolutionary continuum of this
relationship. Thus, during parasitization some parasites de-
liver not only venom and VR oviduct proteins, which may
disrupt lepidopteran host physiology, but also the genetic
capacity for the continued synthesis of VR proteins from
virally encoded genes. We propose that for some parasites,
the parasite egg is initially protected from recognition by the
host immune system by soluble venom and/or oviduct pro-
teins injected at the time ofoviposition. Continued protection
for the parasite during its development could be dependent
upon the expression of VR genes from the viral genome.
When venom secretions are not required, the early and
continuous expression of VR genes from the polydnavirus
may provide the essential functions for parasite survival.
CsPDV gene families are expressed in both the parasite and
the lepidopteran host after parasitization. The rep gene family
is identified by an imperfect 540-base-pair repeat element that
Proc. Natl. Acad. Sci. USA 87 (1990)
Proc. Natl. Acad. Sci. USA 87 (1990) 4965
is present on the majority of the superhelical DNA segments
as single or tandem repeats. Members of the rep gene family
may be expressed in either the parasite or the lepidopteran
host, or in both (15). Another gene family from CsPDV
segmentW encodes the related mRNAs of 1.0 and 1.6 kb that
are expressed only in parasitized larvae (31). In our study,
hybridization analysis showed that members ofa putative VR
gene family are present both in nonviral C. sonorensis
chromosomal DNA and in viral genomic DNA. This indicates
that VR gene expression occurs not only from the CsPDV but
also from nonviral genes in the parasitic wasp. Our prelim-
inary DNA sequence analysis of the VR oviduct and viral
clones supports the dot blot and RNA gel blot analysis and
shows that the hybridization reported herein is not due to
highly repetitive sequences (unpublished data). Since the
polydnavirus is integrated into wasp genomic DNA (12), the
evolutionary potential for genetic transfer between the wasp
and its virus clearly exists and may provide one explanation
for the conserved antigenic relationships between venom and
viral proteins.
Host-related viral proteins and functions have been de-
scribed for many viruses (38-40). In vaccinia viruses, viral
homologs of host genes regulating both cellular proliferation
and the immune system have been identified. Viral expres-
sion of host-related genes may allow a virus to induce
localized cellular proliferation (39), alter the immune re-
sponse to the virus (40), or maintain the host in a develop-
mental state that is advantageous for viral growth (41). In
these examples viral expression of a host-related gene has a
possible or apparent benefit only for the virus. However,
CsPDV is unusual in that viral expression is essential for
endoparasite development. This may represent a virus/host
system in which a virally encoded homolog of a host gene is
expressed to the apparent benefit of both the eukaryotic
endoparasite host and the virus. The packaging of VR genes
into a viral form may facilitate the mobility and targeting of
these genetic units for expression in tissues that may be
otherwise inaccessible to the parasite, thereby enhancing the
regulation of host physiology and development.
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